Increased peptidylarginine deiminase type II in hypoxic astrocytes

被引:29
作者
Sambandam, T
Belousova, M
Accaviti-Loper, MA
Blanquicett, C
Guercello, V
Raijmakers, R
Nicholas, AP [1 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Dept Neurol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Med, Dept Med, Div Genet & Translat Med,Epitope Recognit Immunor, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Med, Dept Pharmacol, Birmingham, AL 35294 USA
[4] Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands
[5] Vet Adm Med Ctr, Dept Neurol, Birmingham, AL 35233 USA
关键词
peptidylarginine deiminase type II; real-time PCR; western blot; astrocytes; citrulline; glial fibrillary acidic protein; ischemia; stroke; gliosis; post-translational modification;
D O I
10.1016/j.bbrc.2004.10.173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptidylarginine deiminase type 11 (PAD 2) is the primary enzyme responsible for conversion of protein bound arginine to citrulline in the central nervous system. Evidence suggests that glial fibrillary acidic protein (GFAP), the main intermediate filament in astrocytes, is deiminated, but not much is known regarding factors that control this enzymatic reaction. The present study demonstrated that PAD 2 activity (as determined by Western blot analysis of citrullinated GFAP isoforms) was increased in human cultured astrocytes by hypoxic conditions. PAD 2 mRNA increased markedly during the first 2 h of hypoxia, but using a single chain antibody against human PAD 2 produced from the ETH-2 phage library, it took approximately 8 It of hypoxia to see marked increases in PAD 2 protein. Thus, this is the first report to demonstrate a measurable response in the amounts of PAD 2 mRNA, protein and activity in human astrocytes by prolonged hypoxic exposure. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1324 / 1329
页数:6
相关论文
共 40 条
[1]  
Abu Rus'd A, 1999, EUR J BIOCHEM, V259, P660
[2]   Localization of peptidylarginine deiminase type II in a stage-specific immature oligodendrocyte from rat cerebral hemisphere [J].
Akiyama, K ;
Sakurai, Y ;
Asou, H ;
Senshu, T .
NEUROSCIENCE LETTERS, 1999, 274 (01) :53-55
[3]   IMMUNOCYTOCHEMICAL DEMONSTRATION OF SKELETAL-MUSCLE TYPE PEPTIDYLARGININE DEIMINASE IN VARIOUS RAT-TISSUES [J].
AKIYAMA, K ;
INOUE, K ;
SENSHU, T .
CELL BIOLOGY INTERNATIONAL REPORTS, 1990, 14 (03) :267-273
[4]   Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages [J].
Asaga, H ;
Yamada, M ;
Senshu, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 243 (03) :641-646
[5]   Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain [J].
Asaga, H ;
Akiyama, K ;
Ohsawa, T ;
Ishigami, A .
NEUROSCIENCE LETTERS, 2002, 326 (02) :129-132
[6]   Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration [J].
Asaga, H ;
Ishigami, A .
NEUROSCIENCE LETTERS, 2001, 299 (1-2) :5-8
[7]   COMBINED BIOCHEMICAL AND IMMUNOCYTOCHEMICAL ANALYSES OF POSTMORTEM PROTEIN DEIMINATION IN THE RAT SPINAL-CORD [J].
ASAGA, H ;
SENSHU, T .
CELL BIOLOGY INTERNATIONAL, 1993, 17 (05) :525-532
[8]   Protein deimination in the rat brain: Generation of citrulline-containing proteins in cerebrum perfused with oxygen-deprived media [J].
Asaga, H ;
Ishigami, A .
BIOMEDICAL RESEARCH-TOKYO, 2000, 21 (04) :197-205
[9]  
Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46
[10]   Apoptotic mitochondrial pathway in neurones and astrocytes after neonatal hypoxia-ischaemia in the rat brain [J].
Benjelloun, N ;
Joly, LM ;
Palmier, B ;
Plotkine, M ;
Charriaut-Marlangue, C .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (04) :350-360